Clinical Trial Update: Safety, Tolerability and Preliminary Efficacy of AZD5213 in Combination With Pregabalin in Subjects With PDN and Good Pain Reporting Ability [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated safety, tolerability and preliminary efficacy of AZD5213 in combination with pregabalin in adults with painful diabetic peripheral …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Painful Diabetic Neuropathy

Drugs mentioned

• AZD5213 (AZD5213)
• Pregabalin (Pregabalin)

Snippet

Sponsor: AstraZeneca | Conditions: Diabetic Neuropathy, Painful; Diabetic Neuropathies | Phase 2 | Status: COMPLETED | Results posted: 2016-10-03